close

Enter

Log in using OpenID

Outsourced Drug Discovery Market Revenue Growth Predicted by 2026

embed
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, a
Outsourced Drug Discovery Market To Register
Unwavering Growth by 2026
Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and
Large Molecule Drugs), by Services (Preclinical Developments, Target validation
and Functional Informatics, Target Identification and Screening, Lead
Identification and Candidate Optimization, and Others), by Application
(Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective
Drugs, Dermatology, Neurology, Cardiology, and Others), by End Users
(Pharmaceutical and Biotechnological Companies, Contract research
Organization, and Contract Manufacturing Organization), by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size,
Share, Trends, and Forecast 2019 - 2026
Outsourced drug discovery is a contract-based process, which is conducted by the contract research
organizations (CRO) and contract manufacturing organization (CMO). Contract research organization
provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery
and development. CRO facilitates the various services such as biopharmaceutical development,
biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug
discovery and development.
Market Dynamics
New strategies adopted by key players related to outsourcing drug discovery is expected to drive
growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline
(GSK), a British drug manufacturing company collaborated with the University of California to
establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research
(LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and
also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.
Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery
market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its
partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL)
extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The
respiratory program is related to the preclinical drug development for treatment of respiratory diseases
and rare diseases.
Request For a Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/2847
Increasing number of drug discovery companies is expected to drive growth of the global
outsourced drug discovery market
Increasing number of new drug discovery companies is expected to drive the global outsourced drug
discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi
AppTec and launched new drug discovery company, Faxian Therapeutics (Headquarter– New York,
U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s
drug design and synthesis services to improve health care needs.
Global Outsourced Drug Discovery Market - Competitive Landscape
Key players operating in the global outsourced drug discovery market are Aurigene Accelerating
Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec
AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia
Meditech Co. Ltd.
Detailed Segmentation:
•Global Outsourced Drug Discovery Market, By Drug Type:
•Small Molecule Drugs
•Large Molecule Drugs
•Global Outsourced Drug Discovery market, By Services:
•Preclinical Development
•Target Validation and Functional Informatics
•Target Identification and Screening
•Lead Identification and Candidate Optimization
•Others
•Global Outsourced Drug Discovery Market, By Application
•Oncology
•Ophthalmology
•Hematology
•Immunomodulation
•Anti-Infective Drugs
•Dermatology
•Pulmonology
•Cardiology
•Others
•Global Outsourced Drug Discovery market, By End User
•Pharmaceutical and Biotechnological Companies
•Contract Research Organization
Global Outsourced Drug Discovery Market- Regional Analysis
North America outsourced drug discovery market is expected to account for the largest market share,
owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic
Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With
this acquisition, Lambda Therapeutic Research entered into the U.S. market.
Moreover, Europe is also projected to witness significant growth in the global outsourced drug
discovery market, owing to increasing merger and acquisition activities by key players in the region.
For instance, in February 2019, Optimapharm, a clinical research organization (CRO) in Europe
acquired Denothex, a CRO, for strengthening its presence in the European market particularly in
France, Spain, Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe
and Israel.
Asia Pacific is also projected to witness significant growth in the global Outsourced Drug Discovery
Market, owing to increasing launches of IT infrastructure investment programs (Trial Management
and Monitoring Cloud Service Implementation Program) for development of clinical trials. For
instance, in December 2018, Novotech, a CRO, launched new Oracle Trial Management and
Monitoring Cloud Service Implementation Program (TMMCS) in Asia-Pacific.TMMCS helps to
maintain centralized trial management database and clinical research associate productivity. TMMCS
provides various benefits including better trial results, improved investigator relationship, and lower
trial costs.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran298   documents Email
Document
Category
Health and Medicine
Views
2
File Size
392 KB
Tags
outsourced
1/--pages
Report inappropriate content